ACCEL Lite: Use of MRA and Outcomes in HFrEF

Jan 19, 2021   |  Alison Bailey, MD, FACC; Nosheen Reza, MD, FACC; John J. V. McMurray, MD, FACC

Podcast

Font Size
A
A
A

In this interview, John McMurray, MD, and Alison Bailey, MD, with Nosheen Reza, MD, discuss the use of mineralocorticoid-receptor antagonist and outcomes in heart failure with reduced ejection fraction.

Like what you hear? ACCEL Subscribers enjoy 20+ insider interviews like these every month, with CME/MOC credit and other exclusive benefits. Subscribe today for more, and check out what's new at www.acc.org/ACCEL.

Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL

Clinical Topics: Heart Failure and Cardiomyopathies, Acute Heart Failure

Keywords: ACCELLite, Heart Failure, Mineralocorticoid Receptor Antagonists


< Back to Listings